Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...

This biotech has already made impressive contributions to medicine, and it could make more. But does that make it a buy?

As part of efforts against malaria, Diaspora Solution Group Nigeria is set to launch a groundbreaking malaria attenuation project, ...

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...

‎DSGN is partnering with Sickle Cell Warriors and Troptions Unity Token to launch the national-scale initiative aimed at ...

Only one in every six million people have the Rh null blood type. Now researchers are trying to grow it in the laboratory in ...

Rh-null is a rare and unique blood type, often referred to as 'Golden Blood'. This blood type is found in less than 50 people ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

Federal Chancellor Friedrich Merz visited the Max Planck Institute of Microstructure Physics in Halle as part of his ...

Basic research may seem far removed from everyday technology, yet it often provides the spark for major industrial shifts.

For the first time, thanks to CRISPR scissors, the genome of reptiles has been edited. American researchers have managed to ...